Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore various ways to build wealth for retirement at age 50. Take actionable steps toward financial success.
17,116 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Accenture has ordered associate directors and senior managers to demonstrate regular AI tool usage to be considered f...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
This analysis unpacks Interface (Tile)'s Q4 2025 earnings, translating numbers into a practical view for investors. L...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...
Five U.S. tech giants have $662 billion in future data-center leases not yet begun, a hidden liability Moody’s says c...
The software sector has faced a tough stretch, dragging some quantum plays into the red. This guide dives into whethe...
2026 could be a pivotal year for NVIDIA as AI demand reshapes its earnings trajectory. This guide breaks down the dri...
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Investors are eyeing OneSpan’s 2025 earnings as the company scales its digital identity and security solutions. This ...
The allure of a $16 billion contracted revenue pipeline can blind investors to real dangers. This article breaks down...